Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider

Background Type I interferons (IFN-I) contribute to a broad range of rheumatic and musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of IFN-I pathway activation may have clinical value. Although several IFN-I pathway assays have been proposed, the exact clinical appl...

Full description

Bibliographic Details
Main Authors: Mary K Crow, Lars Rönnblom, Dimitrios T Boumpas, Robert Biesen, George Bertsias, Marie-Louise Frémond, Marie Wahren-Herlenius, Giulio Cavalli, Maija-Leena Eloranta, Javier Rodríguez-Carrio, Marianne Visser, P G Conaghan, Agata Burska, Willem A Dik, Ed Vital, Jan Rehwinkel, Marjan Versnel
Format: Article
Language:English
Published: BMJ Publishing Group 2023-03-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/1/e002864.full

Internet

https://rmdopen.bmj.com/content/9/1/e002864.full

Similar Items